Keytruda (Pembrolizumab) Issued New Dosage and Indication

The FDA has recently approved new dosage form and two new indications for the drug.  

Source: CancerNetwork - April 22, 2019 Category: Cancer & Oncology Authors: Drew Boxler Source Type: news